AXIM Biotechnologies
AXIM Biotechnologies, Inc. is a research and development company headquartered in San Diego, California, focused on advancing diagnostics and treatments for oncology and infectious diseases, including COVID-19. The company has developed NeuCovix, a rapid diagnostic test designed to measure levels of functional neutralizing antibodies that may prevent SARS-CoV-2 from entering host cells. In addition to its work in infectious diseases, AXIM Biotechnologies is also engaged in creating rapid diagnostic tests for early cancer detection and developing proprietary small molecule drugs aimed at treating cancer and inhibiting metastasis. Founded in 2010, the company is committed to innovation in biotechnology and maintains a diverse portfolio that includes pharmaceutical, nutraceutical, and cosmetic products.
Top Regions
Top Stages
1 past transactions
Sapphire Biotech
Acquisition in 2020
Sapphire Biotech, Inc. is a research and development company based in San Diego, California, focused on improving global cancer care. Established in 2019, the company specializes in creating proprietary therapeutics aimed at inhibiting cancer growth and metastasis. In addition to its therapeutic initiatives, Sapphire Biotech is also engaged in the development of innovative diagnostics designed for early cancer detection, monitoring treatment responses, and assessing recurrence. Through these efforts, the company seeks to enhance patient outcomes and advance the field of oncology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.